Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level - An Observational Study.
NURIPH tool
medication error
nurses and midwives
patient safety
pharmacotherapy
risk management
Journal
Therapeutics and clinical risk management
ISSN: 1176-6336
Titre abrégé: Ther Clin Risk Manag
Pays: New Zealand
ID NLM: 101253281
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
08
2020
accepted:
26
09
2020
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
13
11
2020
Statut:
epublish
Résumé
Pharmacological errors are among the most common in the healthcare system. This study aimed to determine the level of safety of the pharmacotherapy process at the stage performed by nurses and midwives by indicating the key risk factors affecting patients' safety. A group of 1276 nurses and 136 midwives in Poland participated in the study. The survey was conducted in the period from May 2019 to August 2019. The original Nursing Risk in Pharmacotherapy (NURIPH) tool was used. The Cronbach alpha coefficient was 0.832. The low legibility of the medical orders (item 1) was indicated as the highest risk. A mean of 4.50 means that this factor's significance is assessed between "very significant" and "significant." The communication between physician, nurse and midwife, time pressure, and work organization were also rated high (Items 2, 3, and 4). The averages for these factors are higher than 4, so their evaluation is more than "significant.". Nurses and midwives involved in the pharmacotherapy process are exposed to many ergonomic factors triggering risk. A huge problem is the lack of readability of medical orders, which may be a factor triggering a medical error.
Identifiants
pubmed: 33177830
doi: 10.2147/TCRM.S276901
pii: 276901
pmc: PMC7649244
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1057-1065Informations de copyright
© 2020 Witczak et al.
Déclaration de conflit d'intérêts
No conflict of interest has been declared by the authors.
Références
Int J Nurs Stud. 2016 Nov;63:162-178
pubmed: 27637011
Ther Clin Risk Manag. 2015 Mar 05;11:393-406
pubmed: 25767393
Int J Health Policy Manag. 2018 Sep 18;7(12):1090-1096
pubmed: 30709084
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
QJM. 2009 Aug;102(8):513-21
pubmed: 19458202
Br J Nurs. 2017 Feb 9;26(3):159-165
pubmed: 28185490
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5522-5529
pubmed: 31298407
Ther Clin Risk Manag. 2019 Apr 02;15:549-556
pubmed: 31037029
Ind Health. 2010;48(3):357-64
pubmed: 20562512
Lancet. 2017 Apr 29;389(10080):1680-1681
pubmed: 28463129
Br J Nurs. 2014 Jun 12-25;23(11):552, 553-9
pubmed: 24933543
Int J Nurs Stud. 2016 Jan;53:342-50
pubmed: 26365701
BMC Health Serv Res. 2011 Aug 18;11:199
pubmed: 21851620
Int J Nurs Stud. 2015 Jan;52(1):403-20
pubmed: 25443300
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7058-7062
pubmed: 32633400
Pharmacoepidemiol Drug Saf. 2017 May;26(5):481-497
pubmed: 28295821
Nurs Res. 2008 Sep-Oct;57(5):302-11
pubmed: 18794714
BMJ. 2018 Aug 8;362:k3424
pubmed: 30089631
J Occup Health. 2008;50(2):181-90
pubmed: 18403869
Epidemiol Health. 2017 May 17;39:e2017022
pubmed: 28774169